Ipca Laboratories consolidated net profit rises 32.76% in the September 2026 quarter

Sales rise 13.83% to Rs 2909.94 crore

Net profit of Ipca Laboratories rose 32.76% to Rs 375.13 crore in the quarter ended September 2026 as against Rs 282.57 crore during the previous quarter ended September 2025. Sales rose 13.83% to Rs 2909.94 crore in the quarter ended September 2026 as against Rs 2556.50 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	2909.94	2556.50	14
OPM %	23.14	21.32	-
PBDT	685.94	553.17	24
PBT	571.43	449.84	27
NP	375.13	282.57	33

Powered by Capital Market - Live News